Detalles de la búsqueda
1.
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Lancet Oncol
; 23(2): 248-258, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35030333
2.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Cancer
; 128(5): 966-974, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34784056
3.
A review of vitamin use for the prevention or treatment of prostate cancer.
BJU Int
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38741452
4.
The Overall Survival Benefit in EV-302: Is Enfortumab Vedotin plus Pembrolizumab the New Frontline Standard of Care for Metastatic Urothelial Carcinoma?
Eur Urol Oncol
; 7(3): 313-315, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485615
5.
Supplement Use and Increased Risks of Cancer: Unveiling the Other Side of the Coin.
Cancers (Basel)
; 16(5)2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473246
6.
A remnant never forgotten: the utility of circulating tumor DNA in treatment guidance of urachal cancer.
Ther Adv Med Oncol
; 16: 17588359241230743, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38425988
7.
Prostate Cancer in Sexual Minorities: Epidemiology, Screening and Diagnosis, Treatment, and Quality of Life.
Cancers (Basel)
; 15(9)2023 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37174119
8.
Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry.
Prostate Cancer Prostatic Dis
; 2023 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37798437
9.
Outcomes of Patients with Advanced Urothelial Carcinoma after Anti-programmed Death-(ligand) 1 Therapy by Fibroblast Growth Factor Receptor Gene Alteration Status: An Observational Study.
Eur Urol Open Sci
; 47: 48-57, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36601039
10.
Management of Fibroblast Growth Factor Inhibitor Treatment-emergent Adverse Events of Interest in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
Eur Urol Open Sci
; 50: 1-9, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101768
11.
Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma.
Eur Urol Open Sci
; 58: 28-36, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37954037
12.
Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma.
Clin Med Insights Oncol
; 16: 11795549221126252, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36186672
13.
Late recurrence of localized pure seminoma in prostate gland: A case report.
World J Clin Oncol
; 13(1): 62-70, 2022 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116233
14.
Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.
Am J Clin Exp Urol
; 10(4): 210-233, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36051616
15.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.
J Immunother Cancer
; 10(2)2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35210307
16.
Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial.
BMJ Open
; 12(9): e058396, 2022 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36104138
17.
Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial.
Eur J Cancer
; 160: 61-71, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34802864
18.
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma.
Case Rep Oncol
; 14(2): 1051-1058, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326741
19.
Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy.
World J Clin Oncol
; 12(3): 183-194, 2021 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767973
20.
Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE).
Cancer Chemother Pharmacol
; 88(1): 25-37, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33754187